History: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
m (→GlyGen History) |
||
| Line 2: | Line 2: | ||
* William (Will) York (CCRC, University of Georgia, Athens) and Raja Mazumder (The George Washington University), along with their team, founded GlyGen. | * William (Will) York (CCRC, University of Georgia, Athens) and Raja Mazumder (The George Washington University), along with their team, founded GlyGen. | ||
* Raja and | * Raja and Will each wrote separate [https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-14-012.html NIH R34] grants in 2015 for planning a glycoinformatics resource. Both were independently funded. Rather than competing, they collaborated and jointly submitted the GlyGen proposal as Principal Investigators (PIs). | ||
* Raja's planning grant was | * Raja's planning grant was titled GlycoCentral: Glycobiology Data and Tool Integration with Genes, Proteins, and Lipids, while Will's grant was named GlySpace: An Integrated Infrastructure for Glycoinformatics. | ||
* In 2016, during the planning phase, Will and Raja organized meetings at George Washington University (GW), bringing together experts from the glyco, genomics, and biocuration communities. They gathered over 100 use cases to guide the project. | * In 2016, during the planning phase, Will and Raja organized meetings at George Washington University (GW), bringing together experts from the glyco, genomics, and biocuration communities. They gathered over 100 use cases to guide the project. | ||
* Working with Rene Ranzinger and Nathan Edwards, they came up with the name "GlyGen" and developed the content for the first GlyGen U01 proposal, incorporating insights from collected use cases. | * Working with Rene Ranzinger and Nathan Edwards, they came up with the name "GlyGen" and developed the content for the first GlyGen U01 proposal, incorporating insights from collected use cases. | ||
* The GlyGen proposal was submitted by Will and Raja as joint Principal Investigators (PIs). | * The GlyGen [https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-16-021.html NIH U01] proposal was submitted by Will and Raja as joint Principal Investigators (PIs). | ||
* Following Will’s retirement, Michael (Mike) Tiemeyer assumed his role. In the current GlyGen Phase 2 (R24), Raja and Mike serve as Principal Investigators (PIs), with Rene Ranzinger (CCRC, University of Georgia, Athens) and Robel Kahsay (The George Washington University) as Co-Investigators. | * Following Will’s retirement, Michael (Mike) Tiemeyer assumed his role. In the current GlyGen Phase 2 ([https://grants.nih.gov/grants/guide/pa-files/PAR-22-065.html NIH R24]), Raja and Mike serve as Principal Investigators (PIs), with Rene Ranzinger (CCRC, University of Georgia, Athens) and Robel Kahsay (The George Washington University) as Co-Investigators. | ||
* Nathan Edwards (Georgetown University), Maria Martin (EBI), and Vijay Shanker (University of Delaware) contribute as sub-award investigators. | * Nathan Edwards (Georgetown University), Maria Martin (EBI), and Vijay Shanker (University of Delaware) contribute as sub-award investigators. | ||
Revision as of 15:00, 14 March 2025
GlyGen History
- William (Will) York (CCRC, University of Georgia, Athens) and Raja Mazumder (The George Washington University), along with their team, founded GlyGen.
- Raja and Will each wrote separate NIH R34 grants in 2015 for planning a glycoinformatics resource. Both were independently funded. Rather than competing, they collaborated and jointly submitted the GlyGen proposal as Principal Investigators (PIs).
- Raja's planning grant was titled GlycoCentral: Glycobiology Data and Tool Integration with Genes, Proteins, and Lipids, while Will's grant was named GlySpace: An Integrated Infrastructure for Glycoinformatics.
- In 2016, during the planning phase, Will and Raja organized meetings at George Washington University (GW), bringing together experts from the glyco, genomics, and biocuration communities. They gathered over 100 use cases to guide the project.
- Working with Rene Ranzinger and Nathan Edwards, they came up with the name "GlyGen" and developed the content for the first GlyGen U01 proposal, incorporating insights from collected use cases.
- The GlyGen NIH U01 proposal was submitted by Will and Raja as joint Principal Investigators (PIs).
- Following Will’s retirement, Michael (Mike) Tiemeyer assumed his role. In the current GlyGen Phase 2 (NIH R24), Raja and Mike serve as Principal Investigators (PIs), with Rene Ranzinger (CCRC, University of Georgia, Athens) and Robel Kahsay (The George Washington University) as Co-Investigators.
- Nathan Edwards (Georgetown University), Maria Martin (EBI), and Vijay Shanker (University of Delaware) contribute as sub-award investigators.